Organovo Holdings, Inc

We are pioneering a unique set of therapeutic and drug profiling capabilities based on our revolutionary ability to 3D bioprint tissues that mimic key aspects of human biology and disease. We intend to fundamentally alter the drug discovery landscape by the development of novel therapies for disease which have a much higher chance of efficacy in the clinic focused on human primary cell 3D models of disease that more faithfully recapitulate disease processes. Learn more at www.organovo.com

3d bioprinting,3d printing,drug discovery and development,human disease research,and human disease models

Organovo holdings, inc operates in the Biotechnology research industry.

Organovo holdings, inc's revenue is < 1m

Organovo holdings, inc has 11 - 50 employees.